Entrada Therapeutics
Entrada Therapeutics is a clinical-stage biopharmaceutical company founded in 2016 that develops medicines acting on intracellular targets. Its Endosomal Escape Vehicle platform supports RNA- and protein-based programs for neuromuscular and inherited retinal diseases.
Key facts
| Legal Name | Entrada Therapeutics, Inc. |
|---|---|
| Company Operating Status | Active |
| Full Address | 6 Tide St, Boston, Massachusetts 02210, US |
| Previous Name | CycloPorters, Inc. |
| Stock Symbol | TRDA |
| Ticker Symbol | TRDA |
Open roles at Entrada Therapeutics
- Manager, Commercial Strategy Analytics
- Clinical Scientist (CONSULTANT)
- SEC Reporting & Technical Accounting Consultant
- Senior Clinical Operations Contractor
- Associate Director, Drug Product Development & Manufacturing
- Director, Regulatory Writing
- Associate Director, Analytical Development & Quality Control
Browse Entrada Therapeutics roles by location: Boston, United States
Land a role at Entrada Therapeutics
publicOpen roles & company overview
Every live role, the locations Entrada Therapeutics hires across, and the company facts — all above.
membersAlerts & tailored applications
An email the day Entrada Therapeutics posts a role, a cover letter and résumé bullets tailored to each one, and one-click apply.
Get startedEmail & phone for Entrada Therapeutics are shown to signed-in members. Sign in →